Efficacy and safety of neoadjuvant chemotherapy and immunotherapy in locally resectable advanced esophageal squamous cell carcinoma

BACKGROUND: Esophageal squamous cell cancer (ESCC) patients with the potentially resectable disease most would experience relapse after surgery. Immunotherapy has been reported to improve the prognosis of advanced esophageal cancer and may be a new strategy to prevent this urgent condition’s recurre...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Zhigang, Zheng, Qiang, Chen, Haiquan, Xiang, Jiaqing, Hu, Hong, Li, Hang, Pan, Yunjian, Peng, Yizhou, Yao, Xingxin, Liu, Pengcheng, Sun, Yihua, Li, Bin, Zhang, Yawei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264718/
https://www.ncbi.nlm.nih.gov/pubmed/34277047
http://dx.doi.org/10.21037/jtd-21-340

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264718/
https://www.ncbi.nlm.nih.gov/pubmed/34277047
http://dx.doi.org/10.21037/jtd-21-340

Ejemplares similares